If you still think of The Cigna Group CI as just a traditional health insurer, it may be time for a second look. The company is steadily expanding beyond insurance, building a broader healthcare platform centered on pharmacy services, specialty care and AI-powered solutions. The strategy is beginning to deliver results.
Evernorth, Cigna's health services business, is driving much of the company's transformation. Its pharmacy benefits, specialty pharmacy and care services businesses are helping deliver more affordable, personalized care. In the first quarter of 2026, Evernorth's adjusted revenues grew 9% year over year to $58.4 billion.
Technology is becoming another key growth driver. Cigna is using AI and advanced analytics to streamline prescriptions, identify high-risk patients earlier and improve customer engagement. Its rebate-free Signature pharmacy model aims to lower out-of-pocket drug costs, while AI helps simplify the pharmacy experience.
Cigna is also reshaping its portfolio. Investments in CarepathRx and Shields Health Solutions have strengthened its specialty pharmacy business. It also plans to exit the individual exchange business and is reviewing strategic alternatives for eviCore. These moves should help management direct more resources toward its higher-growth businesses.
Management's confidence in the strategy is growing. Following a strong first quarter, Cigna raised its 2026 adjusted EPS outlook by 10 cents to at least $30.35 per share. Cigna's push beyond traditional health insurance is still unfolding, but its growing focus on AI, specialty pharmacy and healthcare services is opening new avenues for long-term growth.
How Are Cigna's Peers Positioned?
Cigna isn't alone in this shift. Peers in the Medical space, like UnitedHealth Group Incorporated UNH and CVS Health Corporation CVS are also investing in technology-enabled healthcare services, making innovation a key differentiator across the industry.
UnitedHealth is pursuing a similar strategy through Optum, which combines pharmacy services, care delivery and technology. Growth in Optum Rx and commercial fee-based membership supported previous quarter’s results. UNH is also expanding its AI and analytics capabilities while rolling out a transparent, fee-based pharmacy care model.
CVS Health is also broadening its healthcare platform through pharmacy services, digital innovation and care delivery. CVS continues to expand AI-powered member engagement and digital onboarding at Aetna while strengthening CVS Caremark and its Health Care Delivery business.
Cigna’s Price Performance, Valuation & Estimates
Shares of Cigna have risen 1.6% year to date compared with the industry’s 22.8%. growth
Image Source: Zacks Investment Research
From a valuation standpoint, Cigna trades at a forward price-to-earnings ratio of 8.78X compared with the industry average of 17.75X. CI carries a Value Score of C.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Cigna’s 2026 earnings is pegged at $30.39 per share, implying a 1.8% increase from the year-ago period’s level.
Image Source: Zacks Investment Research
Cigna currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Beyond Nvidia: AI's Second Wave Is Here
The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.
See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Cigna Group (CI): Free Stock Analysis Report
UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report
CVS Health Corporation (CVS): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).